Federal Register Notice: FDA has determined that Differin (adapalene) solution, 0.1% was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow the agency to approve ANDAs for adapalene solution, 0.1%, if all other legal and regulatory requirements are met. To view this notice, click here.
